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Aim:We aimed to compare Ankleebrachial index (ABI) and Carotid intima-media thickness
(CIMT) as surrogate markers of significant coronary atherosclerosis in South Indians with
coronary artery disease (CAD).
Methods and results: There were two groups: CAD group (n ¼ 59) and Control group (n ¼ 55).
Mean ABI (0.82  0.06 vs. 1.16  0.11, p < 0.0001) and mean CIMT (0.74  0.22 mm vs.
0.45  0.09 mm, p < 0.0001) were statistically different between two groups. ABI < 0.9
(sensitivity: 91.53%, specificity: 100%) and CIMT > 0.63 mm (sensitivity: 61.02%, specificity:
98.18%) implied significant CAD. ABI and CIMT were negatively correlated to one another.
With increasing severity of CAD, ABI decreased but CIMT increased.
Conclusion: ABI and CIMT are simple noninvasive tools providing insight into coronary
atherosclerosis. They can be done at bedside and easily repeated than coronary angiog-
raphy. ABI < 0.9 is a better surrogate marker of significant coronary atherosclerosis than
CIMT > 0.63 mm in South Indians with CAD.
Copyright ª 2013, Cardiological Society of India. All rights reserved.1. Introduction Atherosclerosis is the major etiology of CAD and it is aCoronary artery disease (CAD) imposes significant economic
burden throughout the world. Coronary angiography remains
the gold standard investigation for identifying CAD. In fact, it
is a luminogram and may not detect the abluminal plaque
growth in the initial stages of coronary atherosclerosis.
Moreover, it is invasive associated with significant interob-
server variability and underestimation of stenosis in the
presence of diffuse disease.(mobile).
zhumalai).
2013, Cardiological Societgeneralized process simultaneously involving multiple ar-
teries in the body. Hence, analysis of peripheral arteries in an
individual with CAD may throw some light upon the degree
of atherosclerosis at the level of coronaries. Ankleebrachial
index (ABI) and Carotid intima-media thickness (CIMT) are
simple noninvasive tools developed based on this principle.
The use of ABI in peripheral arterial disease is well estab-
lished. As the same pathogenesis primarily involves coronary
vasculature, ABI (0.9 or <0.9) can also be used a predictor ofy of India. All rights reserved.
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(<1.00) and a high (1.40), are associated with elevated risk of
cardiovascular disease.4
It’s well-known that increased CIMT is a diagnostic tool in
patients with stroke. CIMT is also increased in subjects with
CAD.5e7 The cut-off value of CIMT varies depending on the
age8,9 and ethnicity.10
There are many studies done in the Western population
regarding the use of ABI and CIMT in CAD but very few are
available in the Indian context, especially in South Indians.
Hence, this study was undertaken.2. Aim
This study aimed to analyze and compare the diagnostic
utilities of ABI and CIMT as surrogate markers of significant
coronary atherosclerosis in South Indians with CAD.Table 1 e Clinical characteristics of the participants of the
study.
Parameters CAD group
n ¼ 59
Control group
n ¼ 55
Age* in years (mean  SD) 58.76  9.27 57.07  9.88
Males# 45 (76.27%) 42 (76.36%)
Females# 14 (23.73%) 13 (23.64%)
Smokers 37 (62.71%) 7 (12.73%)
Diabetics 28 (47.46%) e
Hypertensives 32 (54.24%) 6 (10.91%)
*p¼ 0.348 using unpaired Student’s t test; SD: standard deviation; n:
number of subjects.
#p ¼ 0.991 using Chi-square test.3. Methods
This prospective case controlled study was conducted over a
period of 1 year in Jawaharlal Institute of Postgraduate Medi-
cal Education and Research, a tertiary care hospital located in
Pondicherry, a union territory in Southern part of India.
There were two groups in this study: CAD group and Con-
trol group. Cases for CAD group were chosen from those
routinely undergoing coronary angiography. Individuals with
at least 35 years of age and coronary angiography showing
more than 50% stenosis in at least one major epicardial cor-
onary artery were included in CAD group. The inclusion
criteria for Control group were age and sex matched, non-
diabetic individuals, with 10-year risk of developing cardio-
vascular events less than 10% based on Framingham risk
scoring.11 The parameters included in this risk assessment
were age, gender, total cholesterol, high density lipoprotein
cholesterol, systolic blood pressure, treatment for hyperten-
sion, and cigarette or beedi smoking in the past one month.
This was estimated using an online calculator developed by
Adult Treatment Panel III that could be accessed at ‘http://
www.nhlbi.nih.gov/guidelines/cholesterol’.11
The exclusion criteria were claudication pain, absent pul-
ses, peripheral arterial disease, vasculitis, limb abnormalities,
limb swelling, statin intake for more than 1 year, any associ-
ated cardiac illness other than aortosclerosis and past history
of stroke.
ABI was measured prior to coronary angiography using
pocket Doppler ultrasound with 8 MHz handheld transducer.
The sphygmomanometer cuff was tied just above the elbow in
arms and just above medial malleolus in legs. The ultrasound
transducer was used to locate the arterial Doppler signal distal
to the cuff. The cuff was inflated 30 mmHg above systolic
pressure so that the audible Doppler signal disappeared. Now
the cuff was slowly deflated and the pressure at which
Doppler signal returned was noted as the systolic pressure.
The higher systolic pressure between dorsalis pedis and pos-
terior tibial for each foot was divided by the higher brachial
systolic pressure between the two arms to obtain ABI. ABI wascalculated for both the ankles and the lesser value was chosen
for statistical analysis.
CIMT was measured in the far wall of common carotid
artery, around 1 cm below the carotid bifurcation using high
resolution B mode ACUSON ultrasound machine with 9 MHz
linear phased array transducer. CIMT was the distance be-
tween the leading edges of lumen-intima interface and
media-adventitia interface produced by acoustic impedances
between the tissues of arterial wall at end diastole corre-
sponding to the peak of R wave in electrocardiogram. CIMT
was assessed in both sides of neck and the greater value was
chosen for statistical analysis. Carotid plaque is defined as a
localized thickening of more than 1.5 mm in the intima of
artery.
Multiple measurements of ABI and CIMT were performed
and all were done by a single operator. Ethics committee
approval and informed consent were obtained. We performed
all statistical analyzes using Microsoft Excel 2010 and Graph-
Pad Instat 3.06 softwares. A p-value < 0.05 was considered
statistically significant.4. Results
Overall, 371 subjects were screened and finally 114 subjects
were included in this study with 59 subjects in CAD group and
55 subjects in Control group. Out of 59 cases with CAD, there
were 21 (35.59%) cases of single vessel disease, 26 (44.07%)
cases of double vessel disease and 12 (20.34%) cases of triple
vessel disease. The mean 10-year risk of developing cardio-
vascular events based on FraminghamHeart Study for Control
group was 5.36%.
There were 45 (76.27%) males and 14 (23.73%) females in
the CAD group while the control group had 42 (76.36%) males
and 13 (26.64%) females. The mean  SD of age was
58.76  9.27 and 57.07  9.88 years in CAD and Control groups
respectively (Table 1). There was no statistically significant
difference between these two groups with respect to age
(unpaired Student’s t test; p ¼ 0.348) or gender (Chi-square
test; p ¼ 0.991). CAD group consisted of 28 (47.46%) diabetics,
32 (54.24%) hypertensives and 37 (62.71%) smokers with 20e60
pack years (Table 1). Control group consisted of 6 (10.91%)
hypertensives and 7 (12.73%) smokers with 1.5e5 pack years.
Table 3eAnkleebrachial index and carotid intima-media
thickness between diabetics and non-diabetics within
CAD group.
Parameter Diabetics
n ¼ 28
Mean  SD
Non-diabetics
n ¼ 31
Mean  SD
ABI* 0.82  0.06 0.82  0.05
CIMT# (mm) 0.75  0.24 0.73  0.20
*p ¼ 0.714 and #p ¼ 0.679 using unpaired Student’s t test.
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Control group: 1.16 0.11, unpaired Student’s t test p< 0.0001)
and mean CIMT (CAD group: 0.74  0.22 mm and Control
group: 0.45  0.09 mm, unpaired Student’s t test p < 0.0001)
between the two groups were statistically highly significant
(Table 2). Overall, in the CAD group, there were 54 (91.53%)
cases with ABI < 0.9 and 5 (8.47%) cases with ABI  0.9 (Table
2). Similarly, there were 36 (61.02%) cases with
CIMT> 0.63mmand 23 (38.98%) caseswith CIMT 0.63mm in
the CAD group. There were 22 (37.29%) cases with carotid
plaques in CAD group while none in the Control group had
plaque. There was significant difference (Fisher’s Exact test,
p < 0.0001) between the two groups with respect to the pres-
ence of carotid plaques.
Subgroup analysis (Table 3) between diabetics (n ¼ 28) and
non-diabetics (n ¼ 31) within CAD group did not show signif-
icant difference in the mean values of ABI (0.82  0.06 and
0.82  0.05, p ¼ 0.714) or CIMT (0.75  0.24 and 0.73  0.20,
p ¼ 0.679) using unpaired Student’s t test.
The mean ABI was 0.87, 0.82 and 0.75 in cases with single
vessel, double vessel and triple vessel diseases in CAD group
respectively. One-way ANOVA showed that these values were
statistically different (F ¼ 42.487, p < 0.0001) between these
subgroups. Themean CIMTwas 0.6, 0.73 and 0.94mm in these
subgroups respectively and they were statistically different
(F ¼ 44.552, p < 0.0001, one-way ANOVA). The posthoc test
performed along with ANOVA was Turkey Kramer Multiple
Comparisons test and this also showed statistical significance
( p < 0.001) with respect to ABI and CIMT in these subgroups.
With increase in severity of CAD, ABI decreased (Fig. 1) while
CIMT increased (Fig. 2). Pearson correlation test showed sta-
tistically significant negative correlation between ABI and
CIMT (r ¼ -0.780).0.85
0.9
0.87 
0.82 5. Discussion
Routine screening tests such as resting electrocardiography,
treadmill test and electron-beam computed tomography are
inaccurate in predicting cardiovascular events in adults with
low risk for CAD or asymptomatic persons because many
acute events result from sudden occlusion of a previously
unobstructed coronary artery.12 Therefore, in our study, the
participants in Control group were not routinely subjected toTable 2 e Ankleebrachial index and Carotid intima-
media thickness in CAD and Control groups.
Parameter CAD group
n ¼ 59
Control group
n ¼ 55
ABI
Mean  SD* 0.82  0.06 1.16  0.11
<0.90 54 (91.53%) e
0.90 5 (8.47%) 55 (100%)
CIMT (mm)
Mean  SD* 0.74  0.22 0.45  0.09
>0.63 36 (61.02%) 1 (1.82%)
0.63 23 (38.98%) 54 (98.18%)
*p < 0.0001 using unpaired Student’s t test.these screening tests but recruited based on Framingham risk
scoring with 10-year risk of developing myocardial infarction
and coronary death less than 10%.
Prior studies have concluded that a low ABI is highly spe-
cific but not sensitive for predicting future cardiovascular risk
in individuals with peripheral arterial diseases.13 There is one
trial where ABI was assessed using automated oscillometric
method and it was found that the sensitivity, specificity, and
positive and negative predictive values of ABI < 0.9 in pre-
dicting multivessel CAD were 22%, 96%, 93%, and 34%,
respectively.14 In contrast with this trial, another study done
in African-American population, proved that an ABI  0.90
predicted the presence of 3-vessel or left main CAD with a
sensitivity of 85% and specificity of 77%.15 In patients with
PAD diagnosed based on ABI < 0.9, the prevalence of CAD is
46.88%.16
The normal range (mean 2SE, 95% confidence interval) of
ABI for healthy adults in our study is from 0.94 to 1.38. Taking
0.94 as the lower limit of normal range forABI,wewouldobtain
a sensitivity of 100% and specificity of 96.36%. Since many
studies have shown that ABI < 0.9 is a marker of increased
cardiovascular events,1e3 we took ABI < 0.9 as a surrogate
marker of CAD and found a sensitivity of 91.53%, specificity of
100%, pretest probability of 51.75%, positive predictive value of
100% and a negative predictive value of 91.67%.0.65
0.7
5
0.8
Single Vessel
Disease
Double Vessel
Disease
Triple Vessel
Disease
Mean 
ABI 
0.75 
Fig. 1 e Ankleebrachial index and severity of coronary
artery disease. One-way ANOVA: F [ 42.48, p< 0.0001.
Posthoc test: TurkeyeKramer Multiple Comparisons test,
p< 0.001.
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Fig. 2 e Carotid intima-media thickness and severity of
coronary artery disease. One-way ANOVA: F [ 44.552,
p< 0.0001. Posthoc test: TurkeyeKramer Multiple
Comparisons test, p< 0.001.
i n d i a n h e a r t j o u r n a l 6 5 ( 2 0 1 3 ) 1 3 7e1 4 1140Prior studies had no unanimous opinion about the cut-off
value of CIMT for CAD. According to one study conducted in
Japanese diabetics, CIMT  1.1 mm represents CAD.10 The
maximum values of CIMT for normal Indian population and
CAD are 0.80 and 1.02 mm, respectively.17 There is one more
study which states that the risk of first myocardial infarction
increases with a CIMT  0.822 mm.18 In our study, the
normal range (mean  2SE, 95% confidence interval) of CIMT
for healthy adults is from 0.27 to 0.63 mm. We took
CIMT > 0.63 mm as a surrogate marker of CAD and found a
sensitivity of 61.02%, specificity of 98.18%, pretest probability
of 51.75%, positive predictive value of 97.3% and a negative
predictive value of 70.13%. In published studies, CIMT cut-off
value of 0.67 mm yielded a sensitivity and specificity of 85%
and 72%, respectively, for predicting obstructive coronary
atherosclerosis19 while the cut-off value of 0.87 mm for
maximum CIMT obtained a sensitivity and specificity of 90
and 64%, respectively for the detection of left main CAD.5 In
our study, when a higher cut-off value of 0.8 mm was
considered the upper limit of normal CIMT, specificity
increased to 100% but sensitivity decreased markedly to
16.95%. Hence we took 0.63 mm as the upper limit of normal
CIMT. This cut-off value is lower than that found in other
studies. The probable explanation for a lower cut-off value for
CIMT in our study is that other studies hadmatched cases and
controls with respect to risk factors like diabetes, hyperten-
sion, dyslipidemia, smoking, obesity etc. On the other hand,
the controls in our study were matched with cases only in age
and sex but not for risk factors. Patients with diabetes were
excluded from the control population.Moreover, the inclusion
criteria for Control group incorporated Framingham risk
scoring to calculate 10-year risk of developing cardiovascular
events less than 10% and this was hardly used by other
studies. Another explanation could be that South Indiansmay
have a lower CIMT than other populations. Our study is
limited by small sample size which could have also contrib-
uted to the lower cut-off value for CIMT.Based on sensitivity and specificity, ABI < 0.9 is a better
surrogate marker of CAD than CIMT > 0.63 mm. In our study,
all assessments were performed by a single operator so as to
avoid interobserver variation and multiple readings were
taken in order to avoid intraobserver variation. Earlier done
study also did not show any significant interobserver or
intraobserver variation on repeatedly measuring ABI.20
Studies have shown that significant reduction in CIMT oc-
curs by one year of therapy with statins21 and maximum
regression occurs by 2 years.22 So we excluded all those cases
on statins for more than one year.
As per ATP III guidelines, diabetes mellitus is considered a
CADequivalent.11Hence,ABI is expected to be lowandCIMT to
be high in diabetics compared to non-diabetics. The abnor-
malities in ABI and CIMT are expected to be more pronounced
in diabetics with CAD than in non-diabetics with CAD. On the
contrary, in our study, there was no significant difference in
ABI or CIMT between diabetics and non-diabetics within CAD
group. Themajor reason for this interesting observation is the
quantum of atherosclerosis needed for developing CAD will
not differ between diabetics and non-diabetics. Other reasons
could be the interplay of multiple risk factors in non-diabetics
within CAD group and small sample size.
As mentioned earlier, in our study, the term ‘severity’ of
CAD referred only to the number of major epicardial coronary
arteries having at least 50% stenosis. We did not take into
consideration the degree of stenosis beyond 50% and the type
of coronary artery involved. There was significant difference
in ABI and CIMT among cases with single vessel disease,
double vessel disease and triple vessel disease within the CAD
group. With increase in severity of CAD, ABI decreased but
CIMT increased in our study. Prior studies had shown similar
variation of ABI and CIMT with respect to severity of
CAD.8,10,23e25 A few studies differed in this view; one study
found a weak correlation between CIMT and severity of CAD26
and a couple of studies could not establish a direct association
between ABI and significant CAD.27,28 We also found that ABI
and CIMT were negatively correlated to one another; i.e. with
increase in CIMT there was a decrease in ABI and vice versa.
The definition of carotid plaque is highly variable. In our
study, carotid plaque was defined as a localized thickening of
the intima of carotid artery greater than 1.5 mm.5,29 Carotid
arteries were scanned from the clavicle to the angle of
mandible for luminal plaques, while maximal CIMT was
measured in the far wall of common carotid artery around
10 mm below the bifurcation. Around 37.29% of cases in CAD
group had plaques in carotid artery while none in the Control
group had plaques. Using Fisher’s exact test we found that
there was highly significant difference between CAD and
Control groups with respect to the presence of carotid pla-
ques. Hence, the value of CIMT as a surrogatemarker of CAD is
emphasized by the presence of plaque in carotid arteries.6. Conclusion
Ankleebrachial index and Carotid intima-media thickness are
simple noninvasive diagnostic tools capable of providing
insight into the burden of atherosclerosis at the level of cor-
onaries. Hence they are surrogate markers of significant
i n d i a n h e a r t j o u rn a l 6 5 ( 2 0 1 3 ) 1 3 7e1 4 1 141coronary atherosclerosis. They are very simple to do at
bedside and more easily repeatable than coronary angiog-
raphy. They provide key information even during the early
phase of coronary atheroma formation particularly during the
stage of positive remodeling when the atheromatous plaque
abluminally encroaches on the coronary arteries. This
compensatory hyperenlargement is usually not discernible in
coronary angiography. Moreover there is no place for issues
like radiation hazard, contrast induced nephropathy or
vascular complications which may be encountered during
coronary angiography. ABI < 0.9 is a better surrogate marker
of significant coronary atherosclerosis than CIMT > 0.63 mm
in South Indians with CAD. The presence of carotid plaque
may endorse CIMT as a surrogate marker of CAD. ABI and
CIMT are negatively correlated to one another. Therefore, ABI
decreases but CIMT increases with increasing burden of cor-
onary atherosclerosis.Conflicts of interest
All authors have none to declare.r e f e r e n c e s
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